Login to Your Account

Miravant: 'Approvable' Letter Wants Additional AMD Study

By Randall Osborne

Monday, October 4, 2004
A bit of you know what at the end of the tunnel came for Miravant Medical Technologies Inc. in the form of an approvable letter for its light-activated drug to treat age-related macular degeneration, although the FDA is asking for another confirmatory trial. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription